LUDG (Ludwig Enterprises) 14-Day RSI: 17.78 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ludwig Enterprises 14-Day RSI?

Ludwig Enterprises LUDG 14-Day RSI is 17.78 as of Aug. 01, 2026. The stock has 4 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Ludwig Enterprises ranks better than 98.85% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2026-08-01), Ludwig Enterprises's 14-Day RSI is 17.78.

The industry rank for Ludwig Enterprises's 14-Day RSI or its related term are showing as below:

LUDG's 14-Day RSI is ranked better than
98.85% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 46.005 vs LUDG: 17.78

Ludwig Enterprises  (OTCPK:LUDG) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Ludwig Enterprises 14-Day RSI Related Terms


LUDG vs TNON, POAS, XAIR: 14-Day RSI Comparison

For the Medical Devices subindustry, Ludwig Enterprises's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ludwig Enterprises 14-Day RSI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ludwig Enterprises's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Ludwig Enterprises's 14-Day RSI falls into.



Ludwig Enterprises  (OTCPK:LUDG) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 14-Day RSI →
What does a 14-Day RSI of 17.78 mean?
Ludwig Enterprises (LUDG) has a 14-Day RSI of 17.78 as of Aug. 01, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Ludwig Enterprises and its competitors. According to the industry distribution chart, Ludwig Enterprises ranks #10 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 1.2%.
Is Ludwig Enterprises' 14-Day RSI too high?
Ludwig Enterprises' current 14-Day RSI is 17.78. The Medical Devices & Instruments industry median 14-Day RSI is 46.01. Ludwig Enterprises' value of 17.78 is 61.4% below this industry median. Based on the distribution chart, Ludwig Enterprises ranks #10 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Ludwig Enterprises' 14-Day RSI compare to TNON and POAS?
According to the Medical Devices & Instruments industry distribution chart, Ludwig Enterprises ranks #10 out of 866 companies for 14-Day RSI. This places Ludwig Enterprises in the top 1% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 46.01. Ludwig Enterprises' value of 17.78 is 61.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 46.01, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ludwig Enterprises's current 14-Day RSI of 17.78 is 61.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Ludwig Enterprises and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 46.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ludwig Enterprises's current 14-Day RSI is 17.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ludwig Enterprises stock overvalued right now?
Ludwig Enterprises (LUDG) has a current 14-Day RSI of 17.78. The current 14-Day RSI is 17.78 and 61.4% below the Medical Devices & Instruments industry median of 46.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Ludwig Enterprises (LUDG), the current 14-Day RSI is 17.78 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ludwig Enterprises Business Description

Address 8950 SW 74th Ct, Suite 2201-A149, Miami, FL, USA, 33156
Ludwig Enterprises Inc is an early-stage genomic technology company focused on developing screening tests for inflammation-related chronic diseases, including cancers. Its platform integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits designed to provide a differentiated and patient-friendly approach to cancer screening. The company's business model combines a business-to-business-to-consumer (B2B2C) approach with partnerships through CLIA-certified laboratories. It is focused on offering home collection kits directly to patients, supported by certified genetic counselors, while also enabling independent laboratories to provide the Revealia Breast test (Ludwig's key product candidate) as a Laboratory Developed Test (LDT).